Major response to sunitinib (Sutene) in metastatic malignant phyllodes tumor of breast.
Park
In Hae
IH
Center for Breast cancer, National Cancer Center, Gyeonggi-do, Republic of Korea.
Kwon
Youngmee
Y
Kim
Eun-A
EA
Lee
Keun Seok
KS
Ro
Jungsil
J
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D003557:Phyllodes Tumor / Q000473:pathology / Q000628:therapy*; D011758:Pyrroles / Q000627:therapeutic use*; D000077210:Sunitinib; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib